WNK2 and melanoma: Indeed, a recent study implicated Smurf2 overexpression as a mechanism of resistance to mitogen-activated protein kinase kinase (MEK) inhibitors in melanoma and found that Smurf2 depletion sensitized melanoma cells to the cytotoxic effects of selumetinib38.